SEARCH

SEARCH BY CITATION

References

  • 1
    Allen MI, Deslauriers M., Andrews CB, Andrews CW, Tipples CA, Walters KA, Tyrell DLJ, Brown N., Condreay LD (1998) Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 27: 16701677.
  • 2
    Andreone P., Caraceni P., Grazi GL, Belli L., Milandri L., Ercolani G., Jovine E., D'Errico A., Dal Monte PR, Ideo G., Forti D., Mazziotti A., Cavallari A., Bernardi M. (1998) Lamivudine treatment for acute hepatitis B after liver transplantation. J Hepatol 29: 985989.
  • 3
    Bacon TH (1996) Famciclovir, from the bench to the patient - a comprehensive review of preclinical data. Int J Antimicrob Agents 7: 119134.
  • 4
    Bartholomew MM, Jansen RW, Jeffers LL, Reddy KR, Johnson LC, Bunzendahl H., Condreay LD, Tzakis AG, Schiff ER, Brown NA (1997) Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349: 2022.
  • 5
    Ben-Ari Z., Shmueli D., Mor E., Shapira Z., Tur-Kaspa R. (1997) Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 63: 393396.
  • 6
    Chayama K., Suzuki Y., Kobayashi M., Kobayashi M., Tsubota A., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I., Arase Y., Saitoh S., Murashima N., Ikeda K., Kumada H. (1998) Emergence and takeover of YMDD motif mutant hepatitis B virus during longterm lamivudine therapy and re-takeover by wild type after cessitation of therapy. Hepatology 27: 17111716.
  • 7
    Demetris AJ, Todo S., Van Thiel DH (1990) Evolution of hepatitis B virus liver disease after hepatic repleacement. Am J Pathol 137: 667676.
  • 8
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M., Vicary C., Rubin M. (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333: 16571661.
  • 9
    Fabia R., Levy MF, Crippin J., Tillery W., Netto GJ, Aguanno J., Dysert P., Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB (1998) De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg 4: 119127.
  • 10
    Ghany MG, Ayola B., Villamil FG, Gish RG, Rojter S., Vierling JM, Lok ASF (1998) Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27: 213222.
  • 11
    Haller GW, Bechstein WO, Neuhaus R., Raakow R., Berg T., Hopf U., Neuhaus P. (1996) Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation. Transplant Int 9 [Suppl 1]: S210S212.
  • 12
    Honkoop P., Man RA de, Schalm SW (1995) Hepatitis B reactivation after lamivudine. Lancet 346: 11561166.
  • 13
    Klein M., Geoghegan J., Schmidt K., Böckler D., Korn K., Wittekind C., Scheele J. (1997) Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation. Transplantation 64: 162163.
  • 14
    Krüger M., Tillmann HL, Trautwein C., Bode U., Oldhafer K., Maschek H., Böker KHW, Broelsch CE, Pichlmayr R., Manns MP (1996) Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transpl Surg 2: 253263.
  • 15
    Larder BA, Kempt SH, Harrigan RP (1995) Potential mechanisms for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269: 696699.
  • 16
    Main J., Brown JL, Howells C., Galassini R., Crossey M., Karayiannis P., Georgiou P., Atkinson G., Thomas HC (1996) A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepat 3: 211215.
  • 17
    Man RA de, Heijtink RA, Niesters HGM, Schalm SW (1995) New developments in antiviral therapy for chronic hepatitis B infection. Scand J Gastroenterol [Suppl] 212: 100104.
  • 18
    Melegari M., Scaglioni PP, Wands JR (1998) Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication-defective. Hepatology 27: 628633.
  • 19
    Muller R., Samuel D., Fassati LR, Benhamou JP, Bismuth H., Alexander GJM (1994) EUROHEP consensus report on the management of liver transplantation for hepatitis B virus infection. J Hepatol 21: 11401143.
  • 20
    Nery JR, Weppler D., Rodriguez M., Ruiz P., Schiff ER, Tzakis AG (1998) Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation 65: 16151621.
  • 21
    Neuhaus P., Steffen R., Blumhardt G., Bechstein W., Keck H., Lemmens HP, Neuhaus R., Lobeck H., König V., Hopf U. (1991) Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG-positive patients. Transplant Proc 23: 15221524.
  • 22
    Perrillo R., Rakela J., Dienstag J., Levy G., Martin P., Wright T., Caldwell S., Schiff E., Gish R., Villeneuve JP, Farr G., Anschuetz G., Crowther L., Brown N. (1999) Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Hepatology 29: 15811586.
  • 23
    Rakela J., Wooten R., Batt SK, Perkins JD, Taswell HF, Krom RAF (1989) Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 64: 429432.
  • 24
    Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou JP, Bismuth H. (1993) Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 329: 18421847.
  • 25
    Samuel D., Zignego AL, Reynes M., Feray C., Arulnaden JL, David MF, Gigou M., Bismuth A., Mathieu D., Gentilini P., Benhamou JP, Brechot C., Bismuth H. (1995) Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 21: 333339.
  • 26
    Schalm SW, Man RA de, Haijtink RA, Niesters HGM (1995) New nucleoside analogues for chronic hepatitis B. J Hepatol 22 [Suppl 1]: 5256.
  • 27
    Todo S., Demetris AJ, Van Thiel D., Teperman L., Fung JJ, Starzl TE (1991) Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 13: 619626.
  • 28
    Wong DKH, Cheung AM, O'Rourke K., Naylor CD, Detsky AS, Heathcote J. (1993) Effect of α-interferon treatment in patients with hepatitis B e-antigen positive chronic hepatitis B: a meta analysis. Ann Intern Med 119: 312323.
  • 29
    Wright HI, Gavaler JS, Van Thiel DH (1992) Preliminary experience with β-2b-interferon therapy in viral hepatitis in allograft recipients. Transplantation 53: 121124.
  • 30
    Zoulim F., Trépo C. (1998) Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 29: 151168.